BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 23663240)

  • 1. How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter.
    Elit LM; Charles C; Gafni A; Ranford J; Tedford-Gold S; Gold I
    Health Expect; 2015 Oct; 18(5):1066-80. PubMed ID: 23663240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologists' Perceptions of Recurrent Ovarian Cancer Patients' Preference for Participation in Treatment Decision Making and Strategies for When and How to Involve Patients in This Process.
    Elit L; Charles CA; Gafni A
    Int J Gynecol Cancer; 2015 Nov; 25(9):1717-23. PubMed ID: 26501437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Walking a tightrope: oncologists' perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter.
    Elit L; Charles C; Gafni A; Ranford J; Gold ST; Gold I
    Support Care Cancer; 2012 Oct; 20(10):2327-33. PubMed ID: 22167296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What patients value when oncologists give news of cancer recurrence: commentary on specific moments in audio-recorded conversations.
    Back AL; Trinidad SB; Hopley EK; Arnold RM; Baile WF; Edwards KA
    Oncologist; 2011; 16(3):342-50. PubMed ID: 21349951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we be talking about guidelines with patients? A qualitative analysis in metastatic breast cancer.
    Hull O; Niranjan SJ; Wallace AS; Williams BR; Turkman YE; Ingram SA; Williams CP; Smith T; Knight SJ; Bhatia S; Rocque GB
    Breast Cancer Res Treat; 2020 Nov; 184(1):115-121. PubMed ID: 32737711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer.
    Elit L; Charles C; Dimitry S; Tedford-Gold S; Gafni A; Gold I; Whelan T
    Psychooncology; 2010 Mar; 19(3):318-25. PubMed ID: 19319830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Often Relatives are the Key […]" -Family Involvement in Treatment Decision Making in Patients with Advanced Cancer Near the End of Life.
    Laryionava K; Hauke D; Heußner P; Hiddemann W; Winkler EC
    Oncologist; 2021 May; 26(5):e831-e837. PubMed ID: 33037846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives.
    Spellman E; Sulayman N; Eggly S; Peshkin BN; Isaacs C; Schwartz MD; O'Neill SC
    Psychooncology; 2013 Sep; 22(9):2110-6. PubMed ID: 23447452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-oncologist communication in advanced cancer: predictors of patient perception of prognosis.
    Robinson TM; Alexander SC; Hays M; Jeffreys AS; Olsen MK; Rodriguez KL; Pollak KI; Abernethy AP; Arnold R; Tulsky JA
    Support Care Cancer; 2008 Sep; 16(9):1049-57. PubMed ID: 18196288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitators and Barriers to Oncologists' Conduct of Goals of Care Conversations.
    Schulman-Green D; Lin JJ; Smith CB; Feder S; Bickell NA
    J Palliat Care; 2018 Jul; 33(3):143-148. PubMed ID: 29790421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions of Cancer Status Disclosure in Lebanon.
    Temraz S; Salim Hammoud M; Saleh A; Charafeddine M; Mukherji D; Shamseddine A
    J Cancer Educ; 2019 Oct; 34(5):874-881. PubMed ID: 29951903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences.
    Oostendorp LJ; Ottevanger PB; van de Wouw AJ; Honkoop AH; Los M; van der Graaf WT; Stalmeier PF
    J Cancer Educ; 2016 Sep; 31(3):443-8. PubMed ID: 25985960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does silence speak louder than words? The impact of oncologists' emotion-oriented communication on analogue patients' information recall and emotional stress.
    Visser LNC; Tollenaar MS; van Doornen LJP; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2019 Jan; 102(1):43-52. PubMed ID: 30224275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the physician and the older patient: the oncologist's perspective.
    Ganz PA
    Cancer; 1997 Oct; 80(7):1323-5. PubMed ID: 9317186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can communication by oncologists enhance patients' trust? An experimental study.
    Hillen MA; de Haes HCJM; Stalpers LJA; Klinkenbijl JHG; Eddes EH; Butow PN; van der Vloodt J; van Laarhoven HWM; Smets EMA
    Ann Oncol; 2014 Apr; 25(4):896-901. PubMed ID: 24615411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communication Challenges of Oncologists and Intensivists Caring for Pediatric Oncology Patients: A Qualitative Study.
    Odeniyi F; Nathanson PG; Schall TE; Walter JK
    J Pain Symptom Manage; 2017 Dec; 54(6):909-915. PubMed ID: 28807699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectoral communication by bringing together patient with cancer, general practitioner and oncologist in a video-based consultation: a qualitative study of oncologists' and nurse specialists' perspectives.
    Hansen DG; Trabjerg TB; Sisler JJ; Søndergaard J; Jensen LH
    BMJ Open; 2021 May; 11(5):e043038. PubMed ID: 33952540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
    Berry SR; Hubay S; Soibelman H; Martin DK
    BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
    Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
    Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.